The drug assets they have that showed so much promise amounted to little interest from pharma companies despite being promoted by some heavyweights. Their patents have a limited time frame. The phase two trials were encouraging in being effective in helping smokers stop. This could be a big seller in Asia where the incidence of smoking is high and related disease are on the rise, but there has been no indication that they are going to go down that track.
There has been no indication that there is much effort going into promoting the other drug assets. Correct me if I'm missed something.
The focus seems to be on the cancer treatment testing which will take years until they get approval and acceptance.
I hope I'm wrong and will happy to be proven that way.
In the mean time I can only see the sp dropping lower, without some really good announcements there seems no reason for the sp to defy gravity and go up.
IVX Price at posting:
1.7¢ Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)